医学
甲状腺癌
癌
肿瘤科
甲状腺
重症监护医学
内科学
作者
Robert I. Haddad,Lindsay Bischoff,Megan K. Applewhite,Victor Bernet,Erik Blomain,Maria Brito,Naifa L. Busaidy,Michael J. Campbell,Olivia M. DeLozier,Quan‐Yang Duh,Hormoz Ehya,Erin C. Grady,Theresa Guo,Megan R. Haymart,Jason P. Hunt,Fouad Kandeel,Anupam Kotwal,Dominick Lamonica,Jochen H. Lorch,Susan J. Mandel
出处
期刊:Journal of The National Comprehensive Cancer Network
日期:2025-07-01
卷期号:23 (7)
被引量:7
标识
DOI:10.6004/jnccn.2025.0033
摘要
The NCCN Guidelines for Thyroid Carcinoma address the management of different types of thyroid carcinoma, including papillary, follicular, oncocytic, medullary, and anaplastic carcinoma. The NCCN Thyroid Carcinoma Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on the panel’s most recent recommendations regarding systemic therapies for thyroid carcinoma as well as the supporting clinical data.
科研通智能强力驱动
Strongly Powered by AbleSci AI